Kiplinger’s Business Spending Outlook: Caution Prevails as the Economy Slows
Business spending will be on a slowing trend as they conserve cash because of the uncertain outlook and tighter bank lending.
Kiplinger's Economic Outlooks are written by the staff of our weekly Kiplinger Letter and are unavailable elsewhere. Click here for a free issue of The Kiplinger Letter or for more information.
Business spending, especially on capital equipment, will be on a slowing trend. Business optimism picked up in the second quarter, leading to fewer inventory cuts, moderate spending on equipment, and a surge in car and truck purchases as availability improved. But despite the economy’s resilience, it appears to be losing steam gradually, and businesses will likely pull back a bit on their spending. Also, bank lending has tightened in response to the troubles in the banking sector and to the uncertain economic outlook, and interest rates on loans to business borrowers are still high.
Labor costs will continue to rise at a faster-than-usual pace this year. Annual wage growth should ease from 4.4% now to about 3.5% at the end of the year, as the economic slowdown reduces hiring, but wage gains won’t slow their “normal” 3% pace until the end of 2024. Wage growth will be highest in sectors with continuing labor shortages — such as health care — and in the Southern states and Texas, where large in-migration has increased demand for many services.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Supply chains are working again, and the costs of ocean freight and truck transportation have dropped. But many companies that source overseas are facing a dilemma: Go back to the lowest-cost source, even if it’s in China, or bring sourcing closer to home to reduce geopolitical risks? A number of firms are reshoring to the United States, but even more have looked to Mexico as a close but still cheap alternative to China.
Prices of materials have eased in anticipation of slowing world economic growth. Steel and aluminum prices have been coming down. Copper is off its highs, but it won’t fall much because of the lower supply from Chile, a major copper exporter. Commodity prices in general had been expected to rise after China abolished its COVID-19 restrictions and its economy rebounded, but the slowing in Western economies is reducing demand for China’s exports.
Some qualified good news for electric-vehicle battery makers: The prices of lithium and cobalt — two raw materials needed for EV batteries — have dropped rapidly this year, but that’s because battery production has outpaced demand.
Demand for semiconductors has tanked in the consumer electronics sector, so these types of chips are now in abundant supply. But the availability of automotive and other specialty chips is still limited. Ramping up production takes time, as factories take years to build. Another problem: Like most complex industrial machinery, chipmaking equipment requires chips, too. In short, expect limited supply for much of this year in the areas where shortages still exist. But if a recession hits, the remaining shortages would likely ease.
Sources:
David is both staff economist and reporter for The Kiplinger Letter, overseeing Kiplinger forecasts for the U.S. and world economies. Previously, he was senior principal economist in the Center for Forecasting and Modeling at IHS/GlobalInsight, and an economist in the Chief Economist's Office of the U.S. Department of Commerce. David has co-written weekly reports on economic conditions since 1992, and has forecasted GDP and its components since 1995, beating the Blue Chip Indicators forecasts two-thirds of the time. David is a Certified Business Economist as recognized by the National Association for Business Economics. He has two master's degrees and is ABD in economics from the University of North Carolina at Chapel Hill.
-
-
Putting Catch-Up Contributions Into a Roth 401(k) Isn't a Bad Idea
Roth 401(k) High earners will be required to put their catch-up contributions in a Roth 401(k).
By Sandra Block Published
-
Work Email Phishing Scams on the Rise: The Kiplinger Letter
The Kiplinger Letter Phishing scam emails continue to plague companies despite utilizing powerful email security tools.
By John Miley Published
-
Work Email Phishing Scams on the Rise: The Kiplinger Letter
The Kiplinger Letter Phishing scam emails continue to plague companies despite utilizing powerful email security tools.
By John Miley Published
-
Rental Market Will Slow Through 2023: The Kiplinger Letter
The Kiplinger Letter Expected growth in the rental market is likely to remain slow for the rest of the year amid a slow housing market and cooling economy.
By Rodrigo Sermeño Published
-
Tech Giants Look to Curb AI's Energy Demands: The Kiplinger Letter
The Kiplinger Letter The expansion in AI is pushing tech giants to explore new ways to reduce energy use, while also providing energy transparency.
By John Miley Published
-
Passport Processing Times Speed Up: The Kiplinger Letter
The Kiplinger Letter The State Department credits an increase in staff and new technology with shrinking processing times.
By Sean Lengell Published
-
New Employment Guidance Proposed on Hostile Work Practices: The Kiplinger Letter
The Kiplinger Letter New guidelines for employers fueled by a sharp increase in employment discrimination lawsuits in 2023.
By Matthew Housiaux Published
-
SEC Cracks Down on Misleading Fund Names: The Kiplinger Letter
The Kiplinger Letter The SEC rules aim to crack down on so-called “greenwashing” — misleading or deceptive claims by funds that use ESG factors.
By Rodrigo Sermeño Published
-
As Tensions Rise, U.S. Imports From China Shrink: The Kiplinger Letter
The Kiplinger Letter China now accounts for less than 13.5% of American imports from abroad.
By Rodrigo Sermeño Published
-
15 Cancer Drugs Are in Short Supply, FDA reports: The Kiplinger Letter
The Kiplinger Letter The U.S. is working to address cancer drug shortages caused by manufacturing and supply chain woes.
By Matthew Housiaux Published